Advanced Search

 

Study ID Status Title Patient Level Data
206325 Recruiting Qualitative research to characterize the patient experience of nasal polyps
206345 Not yet recruiting HO-16-16593 - Treatment Patterns, Discontinuation and pre-post analysis of Belimumab in the real-world setting
206347 Not yet recruiting HO-16-16611 - SLICC/SDI Indirect Cohort Comparison
206350 Completed Description of QoL data (SF-36 and FACIT) from the BLISS long-term extension study
206351 Not yet recruiting Pooled analysis of the real-world effectiveness of belimumab using multi-country data from the OBSErve studies
206408 Not yet recruiting Disease progression and economic evaluation of clinically important deterioration (CID): conceptual development, applications and validation
206409 Completed Comparative Effectiveness of Early versus Late Start with Umeclidinium/vilanterol
206435 Recruiting Observational Vignette Study to Examine Patient, Healthcare Provider, and Informal Caregiver Perceived Burden of Asthma-Related Exacerbations
206455 Recruiting FF/UMEC/VI: Qualitative Interviews and Discrete Choice Experiment(s) Evaluating the Perceived Benefits of the Features of FF/UMEC/VI (single inhaler triple therapy) Treatment in the UK, US and Germany
206477 Active, not recruiting Administration and Usage Patterns for Albuterol and Asthma Controllers in Patients Using Inhaler Monitoring Technology
206482 Active, Not Recruiting HO-16-17302 - Assessment of adherence and costs in asthma patients using ICS/LABA in the US
206555 Recruiting Burden of disease among patients with eosinophilic COPD in Spain: Multicentre observational study
206577 Recruiting Patient Interviews to Better Understand Disease Experience and Unmet Treatment Needs in Rheumatoid Arthritis
206599 Completed Patient Interviews to Better Understand Disease experience and Unmet Treatment Needs in Hand Osteoarthritis
206605 Recruiting Assessing the Adequacy of the Evaluating Respiratory Symptoms in COPD (E-RS:COPD™) Measure among Patients with Moderate to Severe Asthma
206702 Not yet recruiting Assessment of FF/VI and other ICS/LABA’s on overall healthcare costs and outcomes in patients with COPD in the US
206707 Completed Indirect treatment comparison of ropinirole and pramipexole for management of symptoms in patients with advanced Parkinson’s disease
206764 Completed An open-label study in healthy male subjects, to determine the excretion balance and pharmacokinetics of [14C]-GSK2269557, administered as a single intravenous microtracer (concomitant with an inhaled non-radiolabelled dose) and a single oral dose
206774 Completed A randomized, evaluator-blind, single-center and two arm clinical study designed to evaluate the local tolerance and cosmetic efficacy of a topical skin care formulation in healthy female subjects with mild to advanced photo-damaged facial skin who have undergone a 70% Glycolic Acid facial peel procedure.
206784 Completed Meta-analysis of Rotarix vaccine effectiveness
206807 Not yet recruiting Medical Chart Review Study to Assess the Effectiveness and Safety of Dutasteride versus Finasteride in a Real World Clinical Setting in Patients with Androgenic Alopecia in South Korea
206817 Completed A Single Centre, Double Blind (Sponsor Open), Placebo Controlled, 3-Period Crossover, Ascending Dose Study in Japanese Healthy Elderly Male Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of Danirixin in the Fed State (Part1) and an open label, 2-way crossover to evaluate food effect on the pharmacokinetics of Danirixin (Part2)
206821 Not yet recruiting A randomised open-label study to compare the effectiveness of the fixed dose combination of FF/UMEC/VI (using the Connected Inhaler System) with the combination of FP/SAL plus tiotropium (without the Connected Inhaler System) in participants with inadequately controlled asthma
206822 Completed PGx7659: Exploratory Pharmacogenetic Investigation of Efficacy Response to Relvar/Breo in Asthma studies 106827, 106829, 106837, 113091 and 116863
206823 Completed PGx7660: Exploratory Pharmacogenetic Investigation of Efficacy Response to Relvar/Breo in Phase III COPD studies 112206, 112207, 113108, and 200820

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.